Search Medical Condition
Please enter condition
Please choose location

Kannapolis, North Carolina Clinical Trials

A listing of Kannapolis, North Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (8) clinical trials

The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort

This study is designed to collect information on the current level of symptoms and ability to breathe, treatment and outcomes of patients with Chronic Obstructive Pulmonary Disease (COPD). This information will be used by the researchers to better understand the impact of COPD on patients. It will also help the ...

Phase N/A

0.0 miles

Learn More »

Influence of Instaflex Advanced Supplement on Joint Function

The research procedures will be conducted at the Human Performance Laboratory (Room 1201, Plants for Human Health Institute Building, 600 Laureate Way), operated by Appalachian State University at the North Carolina Research Campus (NCRC) in Kannapolis, NC. Subjects will come here for orientation/baseline testing and then 3 other lab visits ...

Phase N/A

0.0 miles

Learn More »

The Baseline Study

This study is the first initiative of Project Baseline, a broader effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease. ...

Phase N/A

0.0 miles

Learn More »

Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)

Fedovapagon is a selective vasopressin V2 receptor (V2R) agonist that has an antidiuretic effect through stimulation of V2 receptors in the kidney and is being developed for the treatment of nocturia. Nocturia, defined as the complaint that the individual has to wake at night one or more times to void, ...

Phase

7.18 miles

Learn More »

A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

The purpose of this trial is to test if a marketed drug for advanced prostate cancer (FIRMAGON) can reduce the risk of cardiovascular complications as compared to another marketed drug for advanced prostate cancer (LUPRON DEPOT) in patients with prostate cancer and cardiovascular disease.

Phase

7.18 miles

Learn More »

A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to treatment with rucaparib.

Phase

7.18 miles

Learn More »

A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to treatment with rucaparib verses treatment with physician's choice of abiraterone acetate, enzalutamide, or docetaxel.

Phase

7.18 miles

Learn More »

Looking for people who have been diagnosed with Sjögren’s Syndrome to participate in a clinical research study that will evaluate an investigational medication for Sj?gren’s Syndrome

Phase

10.07 miles

Learn More »